Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Henrique Moreira Barbosa

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Arquivos Brasileiros De Cardiologia|May 28, 2025
TIMI Risk Score for Secondary Prevention to Risk Stratify Chronic Coronary Syndrome Patients: External Validation StudyHenrique Trombini Pinesi, Eduardo Martelli Moreira, Marcelo Henrique Moreira Barbosa, et al.
Diabetes Care|April 15, 2025
Empagliflozin in Patients With Type 2 Diabetes Undergoing On-Pump CABG: The POST-CABGDM Randomized Clinical TrialFabio Grunspun Pitta, Eduardo Gomes Lima, Caio Assis Moura Tavares, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Arquivos Brasileiros De Cardiologia|May 28, 2025
TIMI Risk Score for Secondary Prevention to Risk Stratify Chronic Coronary Syndrome Patients: External Validation StudyHenrique Trombini Pinesi, Eduardo Martelli Moreira, Marcelo Henrique Moreira Barbosa, et al.
Diabetes Care|April 15, 2025
Empagliflozin in Patients With Type 2 Diabetes Undergoing On-Pump CABG: The POST-CABGDM Randomized Clinical TrialFabio Grunspun Pitta, Eduardo Gomes Lima, Caio Assis Moura Tavares, et al.
Pageof 1